BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35413833)

  • 21. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.
    Johnson RW; Nguyen MP; Padalecki SS; Grubbs BG; Merkel AR; Oyajobi BO; Matrisian LM; Mundy GR; Sterling JA
    Cancer Res; 2011 Feb; 71(3):822-31. PubMed ID: 21189326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
    Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
    Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of CDK-mediated Smad3 phosphorylation reduces the Pin1-Smad3 interaction and aggressiveness of triple negative breast cancer cells.
    Thomas AL; Lind H; Hong A; Dokic D; Oppat K; Rosenthal E; Guo A; Thomas A; Hamden R; Jeruss JS
    Cell Cycle; 2017 Aug; 16(15):1453-1464. PubMed ID: 28678584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
    Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
    Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parathyroid Hormone-Related Protein Interacts With the Transforming Growth Factor-β/Bone Morphogenetic Protein-2/Gremlin Signaling Pathway to Regulate Proinflammatory and Profibrotic Mediators in Pancreatic Acinar and Stellate Cells.
    Bhatia V; Cao Y; Ko TC; Falzon M
    Pancreas; 2016; 45(5):659-70. PubMed ID: 26495794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
    Isowa S; Shimo T; Ibaragi S; Kurio N; Okui T; Matsubara K; Hassan NM; Kishimoto K; Sasaki A
    Anticancer Res; 2010 Jul; 30(7):2755-67. PubMed ID: 20683010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.
    Xu X; Zhang L; He X; Zhang P; Sun C; Xu X; Lu Y; Li F
    Biochem Biophys Res Commun; 2018 Jul; 502(1):160-165. PubMed ID: 29792857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells.
    Taylor MA; Davuluri G; Parvani JG; Schiemann BJ; Wendt MK; Plow EF; Schiemann WP; Sossey-Alaoui K
    Breast Cancer Res Treat; 2013 Nov; 142(2):341-53. PubMed ID: 24197660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT.
    Zhu Y; Tao Z; Chen Y; Lin S; Zhu M; Ji W; Liu X; Li T; Hu X
    Breast Cancer Res Treat; 2022 May; 193(1):65-81. PubMed ID: 35254603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.
    Wang S; Liu Q; Zhang Y; Liu K; Yu P; Liu K; Luan J; Duan H; Lu Z; Wang F; Wu E; Yagasaki K; Zhang G
    Mol Cancer; 2009 Oct; 8():81. PubMed ID: 19796390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
    Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
    Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TGFβ-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potential.
    Gupta J; Robbins J; Jilling T; Seth P
    Cancer Biol Ther; 2011 Feb; 11(3):311-6. PubMed ID: 21099351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways.
    Keklikoglou I; Koerner C; Schmidt C; Zhang JD; Heckmann D; Shavinskaya A; Allgayer H; Gückel B; Fehm T; Schneeweiss A; Sahin O; Wiemann S; Tschulena U
    Oncogene; 2012 Sep; 31(37):4150-63. PubMed ID: 22158050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human adipose tissue-derived stromal/stem cells promote migration and early metastasis of triple negative breast cancer xenografts.
    Rowan BG; Gimble JM; Sheng M; Anbalagan M; Jones RK; Frazier TP; Asher M; Lacayo EA; Friedlander PL; Kutner R; Chiu ES
    PLoS One; 2014; 9(2):e89595. PubMed ID: 24586900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Berberine Suppresses Cell Motility Through Downregulation of TGF-β1 in Triple Negative Breast Cancer Cells.
    Kim S; Lee J; You D; Jeong Y; Jeon M; Yu J; Kim SW; Nam SJ; Lee JE
    Cell Physiol Biochem; 2018; 45(2):795-807. PubMed ID: 29414799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KPNA3 promotes epithelial-mesenchymal transition by regulating TGF-β and AKT signaling pathways in MDA-MB-231, a triple-negative breast cancer cell line.
    Choi J; Choi JH; Lee HW; Seo D; Lkhagvasuren G; Kim JW; Seo SB; Lee K; Lee KH
    BMB Rep; 2023 Feb; 56(2):120-125. PubMed ID: 36593106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis.
    Wang Y; Lei R; Zhuang X; Zhang N; Pan H; Li G; Hu J; Pan X; Tao Q; Fu D; Xiao J; Chin YE; Kang Y; Yang Q; Hu G
    J Clin Invest; 2014 Apr; 124(4):1646-59. PubMed ID: 24590291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
    Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
    Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collagen Type VI Alpha 3 Chain Promotes Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Transforming Growth Factor β (TGF-β)/Smad Pathway.
    Huang Y; Li G; Wang K; Mu Z; Xie Q; Qu H; Lv H; Hu B
    Med Sci Monit; 2018 Aug; 24():5346-5354. PubMed ID: 30066698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.